900M to ~2B
Global 60+ population to double by 2050
$100B
Longevity therapeutics market by 2030
$1T +
Healthcare costs for aging diseases
By 2050, a doubled global 60+ population (2B) drives a ~$100B longevity market, incentivizing research to reduce disease burden and healthcare costs.
Additional Documentation
Longevity research is an interdisciplinary field dedicated to understanding and slowing the biological mechanisms of aging, ultimately aiming to extend healthy human lifespans. The problem space spans a massive and urgent need: as populations age, age-related diseases—from neurodegenerative disorders like Alzheimer’s to metabolic and cardiovascular conditions—are set to overwhelm healthcare systems and create severe economic burdens. Addressing these challenges calls for innovative funding structures and collaborative models. VitaDAO implements a decentralized approach, using blockchain-based governance to pool resources and support diverse, early-stage research initiatives. By distributing decision-making and funding power among a global community of scientists, investors, and advocates, such decentralized platforms help accelerate discoveries, improve access to cutting-edge treatments, and ensure that longevity research progresses with greater transparency, inclusivity, and efficiency.
Longevity research is an interdisciplinary field dedicated to understanding and slowing the biological mechanisms of aging, ultimately aiming to extend healthy human lifespans. The problem space spans a massive and urgent need: as populations age, ag...
Longevity
Longevity research focuses on understanding and extending the human lifespan by targeting biological aging processes. This includes studying genetics, metabolism, and cellular pathways to develop therapies that reduce age-related diseases and promote healthier, longer lives.
Healthspan
Healthspan research aims to maximize the period of life spent in good health by preventing or delaying age-related diseases. It emphasizes improving physical and cognitive well-being, ensuring that longer lifespans are accompanied by enhanced quality of life.
Rejuvenation
Rejuvenation research explores reversing biological aging at the cellular and molecular levels. By targeting damage accumulation and reactivating youthful pathways, it seeks to restore tissue function, repair age-related decline, and rejuvenate the body’s systems.
64,298,880
Total Supply
＠vita_dao on 𝕏
Discord community
Telegram community
VitaDAO’s value capture is driven by a continuous, self-reinforcing cycle connecting decentralized research funding with IP creation, tokenization, and monetization. The DAO begins by pooling treasury funds from its community of token holders, then carefully identifies, vets, and invests in cutting-edge longevity research projects. Through these investments, VitaDAO supports the development of proprietary research assets, which are captured as intellectual property.
This IP is then tokenized as IP-NFTs and IP tokens (IPTs), forming digital assets that represent tangible rights over scientific IP. VitaDAO also helps incubate new ventures and engages in strategic partnerships and sublicensing deals with commercial partners. These monetization pathways have the ability to monetize DAO’s holdings. Proceeds derived from IP commercialization flow back to the DAO’s treasury, thereby replenishing its capital base.
This cyclical mechanism ensures sustainable growth: as IP gains value, VitaDAO’s treasury grows, enabling more funding of pioneering research and reinforcing the DAO’s influence in the longevity ecosystem.
VitaDAO’s value capture is driven by a continuous, self-reinforcing cycle connecting decentralized research funding with IP creation, tokenization, and monetization. The DAO begins by pooling treasury funds from its community of token holders, then c...
Nature Aging
The economic value of targeting aging
Nature Biotechnology
The community of the DAO
Nature Biotechnology
